What Is the Growth Potential of Oncology Diagnostics in In Vitro Diagnostics?

By leveraging data-driven solutions, co-development opportunities, and assay innovation, clients can experience enhanced product performance, cost-effectiveness, and improved decision-making capabilities


Oncology diagnostics in IVD (In Vitro Diagnostics) is witnessing a lucrative growth rate, with drivers including an increase in cancer incidences, technological developments in diagnostic tests, an increase in screening tests, and supportive government initiatives. Owing to the intense competition in this space, most prominent companies are investing heavily to create new diagnostic tests.

  • Why is colorectal cancer (CRC) the leading revenue generator in oncology diagnostics?
  • Why are liquid biopsies set to be a promising advancement for oncology diagnostics?
  • Why has biomarker analysis received significant interest in oncology diagnosis?

Quick links

Click here to buy this analytics

Already a member? Click here to access the analytics

Request More Information

Sign up for a complimentary Growth Pipeline Dialog™

A Growth Pipeline Dialog is a structured open discussion with our growth experts providing unparalleled market intelligence and proven implementation best practices. This discussion will spark innovative thinking and help generate a pipeline of growth opportunities you can leverage to maximize your company’s future growth potential.